He said rebalancing the country’s vaccine portfolio may occur, as more clinical data is announced and published in due time.“We may add more of a particular vaccine and even not exercise some of the other agreements.
As such, he advised young, healthy Malaysians to manage expectations of when they would receive the vaccine. “Hence, Sinovac declined to include Malaysia in its phase three trial programme. Clinical trials need high infectivity rates to be successful,” he said. The Vaccine Selection Technical Working Group , he added, will regularly update him on clinical data of the vaccines, while the commercial team will advise him on negotiations on price and availability of the vaccines.
Khairykj DrAdhamBaba DGHisham At least if the Vaccine is here it can b done in various phases and people can start to move and work from office and schools etc...with ECONOMY opening up gradually as WE know the Vaccine is a prevention.
Khairykj DrAdhamBaba Why a sudden move to SINOVAC Budget has been approved in Dewan and PAC didn't have a problem with the explanation on the EXPENSES so why then sudden change to another Vaccine brand ? All this will also cause a delay and the People are waiting.
'nimble and flexible' next moment ..... jatuh dalam pothole
why is only Khairykj answering the important q's? can other gov ministers exxercise this kind of accountability to rakyat ?
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.